Human gastric epithelium produces IL-4 and IL-4δ2 isoform only upon Helicobacter pylori infection

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 4, 2007, Pages 809-818

  Orsini, Barbara ^a,d   Vivas, J R ^b   Ottanelli, B ^a   Amedei, A ^a   Surrenti, E ^a   Galli, A ^a   Milani, S ^a   Pinzani, P ^a   Del Prete, G ^a   Surrenti, C ^a   Baldari, C T ^c   Touati, E ^b   D'Elios, M M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF SIENA   (Italy)

^d Department of Clinical Pathophysiology   (Italy)

Author keywords

Helicobacter pylori; Host pathogen interaction; Human gastric epithelium; Interleukin 4; Mucosal immunity; Tolerance

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 DELTA 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGS CELL LINE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; MICRODISSECTION; PATHOGENICITY ISLAND; PRIORITY JOURNAL; SS1 STRAIN; STOMACH EPITHELIUM;

EID: 37749007670     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000417     Document Type: Article

References (42)

1. Marshall B.J. and J.R. Warren. 1984. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 8390:1311.
2. Blaser M.J. and J.C. Atherthon. 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113:321.
3. Israel D.A. and R.M. Peek. 2001. Review article: pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment. Pharmacol. Ther. 15:1271.
4. Censini S., C. Lange, Z. Xiang, J.E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli and A. Covacci. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648.
5. Zhang Y., R.H. Argent, D.P. Letley, R.J. Thomas and J.C. Atherton. 2005. Tyrosine phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS gastric epithelial cells. J. Clin. Microbiol. 43:786.
6. Viala J., C. Chaput, I.G. Boneca, A. Cardona, S.E. Girardin, A.P. Moran, R. Athman, S. Memet, M.R. Huerre, A.J. Coyle, P.S. Di Stefano, P.J. Sansonetti, A. Labigne, J. Bertin, D.J. Philpott and R.L. Ferrero. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol.5:1166.
7. Orsini B., G. Ciancio, S. Censini, E. Surrenti, G. Pellegrini, S. Milani, H. Herbst, A. Amorosi and C. Surrenti. 2000. Helicobacter pylori cag pathogenicity island is associated with enhanced interleukin-8 expression in human gastric mucosa. Digest. Liver Dis. 32:458.
8. Israel D.A., N. Salama, C.N. Arnold, S.F. Moss, T. Ando, H.P. Wirth, K.T. Tham, M. Camorlinga, M.J. Blaser, S. Falkow and R.M. Peek Jr. 2001. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Invest. 107:611.
9. Blaser M.J. 2005. The biology of cag in the Helicobacter pylori-human interaction. Gastroenterology 128:1512.
10. Karttunen R., T. Karttunen, H.P.T. Ekre and T.T. MacDonald. 1995. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36:341.
11. D'Elios M.M., M. Manghetti, F. Almerigogna, A. Amedei, F. Costa, D. Burroni, C.T. Baldari, S. Romagnani, J.L. Telford and G. Del Prete. 1997. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. 27: 1751.
12. Lindholm C., M. Quiding-Jarbrink, H. Lonroth, A. Hamlet and A.M. Svennerholm. 1998. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 66:5964.
13. D'Elios M.M., M. Manghetti, M. De Carli, F. Costa, C.T. Baldari, D. Burroni, J.L. Telford, S. Romagnani and G. Del Prete. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962.
14. Paul W.E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77:1859.
15. Romagnani S. 1993. Regulatory role of IL-4 and other cytokines in the function and development of human T-cell clones. Res. Immunol. 144:625.
16. Minty A., S. Asselin, A. Bensussan, D. Shire, N. Vita, A. Vyakarnam, J. Wijdenes, P. Ferrara and D. Caput. 1997. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur. Cytokine Netw. 8:203.
17. Umland S.P., S. Razac, H. Shah, D.K. Nahrebne, R.W. Egan and M.M. Billah. 1998. Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma. Am. J. Respir. Cell Mol. Biol. 18:631.
18. Vasiliev A.M., R.N. Vasilenko, N.L. Kulikova et al. 2003. Structural and functional properties of IL-4delta2, an alternative splice variant of human IL-4. J. Proteome Res. 2:273.
19. Klein S.C., J.G. Golverdingen, D.F. van Wichen, A.G.M. Bouwens, I. Stuij, M.G.J. Tilanus, E.J.E.G. Bast and R.A. De Weger. 1996. Expression of two interleukin 4 mRNA isoforms in B lymphoid cells. Cell. Immunol. 167:259.
20. Atamas S.P. 1997. Alternative splice variants of cytokines: making a list. Life Sci. 61:1105.
21. Glare E.M., M. Divjak, J.M. Rolland and E.H. Walters. 1999. Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-482. J. Allergy Clin. Immunol. 104:978.
22. Jiang H., C. Liu, J. Xu, B. Sun, S. Pan, H. Qiao, L. Luo and X. Sun. 2004. Gene tranfer of interleukin-4 delays acute rejection of splenic allografts in rats. Transplant. Proc. 36:1600.
23. Saggi B.H., R.A. Fisher, D. Bu, J.W. Tawes, R. Riley and M.P. Posner. 1999. Intragraft cytokine expression and tolerance induction in rat renal allografts. Tranplantation 67:206.
24. Shengwu M., Y. Huang, Z. Yin, R. Menassa, J.E. Brandle and A.M. Jevnikar. 2004. Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. Proc. Natl. Acad. Sci. USA 101:5680.
25. Faria A.M. and H.L. Weiner. 2005. Oral tolerance. Immunol. Rev.206:232.
26. Weiner H.L. 2004. Current issues in the treatment of human diseases by mucosal tolerance. Ann. NY Acad. Sci. 1029:211.
27. Kuipers E.J. and P. Michetti. 2005. Bacteria and mucosal inflammation in the gut: lessons from Helicobacter pylori. Helicobacter. 10(S)1:66.
28. Rumbo M. and E.J. Schiffrin. 2005. Ontogeny of intestinal epithelium immune functions: developmental and environmental regulation. Cell. Mol. Life Sci. 62:1288.
29. Lee A., J. O'Rourke, M. Ungria, D. Robertson, G. Daskalopoulos and M. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection introducing the Sydney strain. Gastroenterology 112:1386.
30. Gray S.F., J.I. Wyatt and B.J. Rathbone. 1986. Simplified techniques for identifying Campylobacter pyloridis (letter). J. Clin. Pathol. 39:1279.
31. Dixon M.F., R.M. Genta, J.H. Yardley and P. Correa. 1996. Classification and grading of gastritis. The updated Sydney System. International Workshop on the histopathology of gastritis, Houston 1994. Am. J. Surg. Pathol. 20:1161.
32. Bock O., G. Lock, U. Schade, R. von Wasielewski, J. Schlue and H. Kreipe. 2005. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. J. Pathol. 205:548.
33. Crabtree J.E., R.L. Ferrero and J.G. Kusters. 2002. The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter. 7:139.
34. Sieveking D., S.T. Leach, H.M. Mitchell and A.S. Day. 2005. Role of serum in epithelial cell responses to Helicobacter pylori infection in vitro. J. Gastroenterol. Hepatol. 20:1610.
35. D'Elios M.M., P. Romagnani, C. Scaletti, F. Annunziato, M. Manghetti, C. Mavilia, P. Parronchi, C. Pupilli, G. Pizzolo, E. Maggi, G. Del Prete and S. Romagnani. 1997. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells J. Leuk. Biol. 61:539.
36. Bijlsma F.J., J. van Kuik, E. van Hoffen, N. de Jonge, M.G.J. Tilanus, F.H.J. Gmelig-Meyling and R.A. de Weger. 2002. Acute cardiac transplant rejection is associated with low frequencies of interleukin-4 producing helper T-lymphocytes rather than with interleukin-4 promoter or splice variants. Hum. Immunol. 63:317.
37. PE Applied Biosystems. 1997. ABI Prism 7000 Sequence Detection System: Relative quantitation of gene expression. Perkin-Elmer User bullettin 2:36.
38. Orsini B., B. Ottanelli, A. Amedei, E. Surrenti, M. Capanni, G. Del Prete, A. Amorosi, S. Milani, M.M. D'Elios and C. Surrenti. 2003. Helicobacter pylori cag pathogenicity island is associated with reduced expression of interleukin-4 (IL-4) mRNA and modulation of the IL-4δ2 mRNA isoform in human gastric mucosa. Infect. Immun. 71:6664.
39. Ferrero R.L. 2005. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol. Immunol. 42:879.
40. Dubois B., A. Goubier, G. Joubert and D. Kaiserlian. 2005. Oral tolerance and regulation of mucosal immunity. Cell. Mol. Life Sci. 62:1322.
41. Rook G.A., R. Hernandez-Pando, K. Dheda and G. Teng Seah. 2004. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 25:483.
42. Demissie A., M. Abebe, A. Aseffa, G. Rook, H. Fletcher, A. Zumla, K. Weldingh, I. Brock, P. Andersen, T.M. Doherty and the VACSEL Study Group. 2004. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2. J. Immunol. 172:6938.